Read More 1 minute read Funding News News TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent… byChris-Anne RoqueNovember 15, 2024